Schedule 13G ownership disclosure

Axsome Therapeutics Inc

Security class unavailable · CUSIP: 05464T104

Event date: Unavailable

Legacy cover-page extraction is best effort and may not include every reporting person.

Filing-level shares
1,300,692
Percent of class
5.5000%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0001105806-17-000010
Form type
SC 13G
Filer
Axsome Therapeutics, Inc.
CIK
CIK 1579428
Filed
Apr 27, 2017
Reporting period
—
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub